PReS-FINAL-2130-A: Effectiveness of intravenous cyclophosphamide in severe or refractory juvenile dermatomyositis - a national cohort study UK and Ireland

por Moraitis, E, Arnold, K, Wedderburn, LR, Pilkington, CA
Publicado 2013

PReS-FINAL-2130: Antibodies to MDA5 correlate with a distinct phenotype in children with juvenile dermatomyositis, including higher risk of lung involvement and ulcerative skin dis...

por Moraitis, E, Tansley, S, Arnold, K, Betteridge, ZE, Gunawardena, H, Jacques, TS, Owens, C, Wedderburn, LR, Mchugh, N
Publicado 2013

Evaluation of magnetic resonance imaging abnormalities in juvenile onset neuropsychiatric systemic lupus erythematosus

por Al-Obaidi, M, Saunders, D., Brown, S., Ramsden, L., Martin, N., Moraitis, E., Pilkington, C. A., Brogan, P. A., Eleftheriou, D.
Publicado 2016

Effective induction therapy for anti-SRP associated myositis in childhood: A small case series and review of the literature

por Binns, E. L., Moraitis, E., Maillard, S., Tansley, S., McHugh, N., Jacques, T. S., Wedderburn, L. R., Pilkington, C., Yasin, S. A., Nistala, K.
Publicado 2017

Systemic juvenile idiopathic arthritis: The Great Ormond Street Hospital experience (2005–2021)

por Foley, C. M., McKenna, D., Gallagher, K., McLellan, K., Alkhdher, H., Lacassagne, S., Moraitis, E., Papadopoulou, C., Pilkington, C., Al Obaidi, M., Eleftheriou, D., Brogan, P.
Publicado 2023